Research and Development Dynamics in the Idiopathic Pulmonary Fibrosis Treatment Market
The demand for idiopathic pulmonary fibrosis (IPF) treatments is experiencing a notable escalation, driven by a combination of rising prevalence rates and heightened patient awareness. The Idiopathic Pulmonary Fibrosis Treatment Market is set to grow from USD 3.89 billion in 2024 to USD 7.963 billion by 2035, reflecting a compound annual growth rate (CAGR) of 6.73%. As more patients are...
0 التعليقات 0 المشاركات 35 مشاهدة 0 معاينة